Beta-Blockers for Panic Disorder: Peripheral Symptom Control vs. the Central Fear Response
A patient convinced his racing heart means something is physically wrong keeps abandoning SSRIs too early to judge them fairly. The debate is whether blunting his physical symptoms with a beta-blocker treats the disorder or just quiets the alarm bell.
Adrian M., a 39-year-old man, is a self-employed electrician who has had panic disorder for roughly two years, well characterized by recurrent attacks featuring a pounding heart, trembling hands, and sweating that he says are the actual reason each attack escalates — he becomes convinced something is physically wrong with his heart the moment he notices the palpitations. He has tried sertraline twice, both times stopped within three weeks for what he described as "not helping" though his own account suggests inadequate trial duration rather than true non-response. He has no cardiac history, a normal prior cardiac workup, and is reluctant to try another SSRI right now.
Propranolol, taken as needed before anticipated triggers or at attack onset, directly blunts the peripheral autonomic symptoms — tachycardia, tremor — that he identifies as the trigger for catastrophic interpretation. What it does not touch is the central fear circuitry itself, and there's real debate whether removing only the peripheral cues meaningfully interrupts the panic cascade for a patient whose attacks are driven as much by interpretation as by the physical sensations themselves.
He mentions, almost as an aside, that he stopped both SSRI trials the same week his symptoms happened to spike for unrelated reasons — a coincidence he read at the time as proof the drug wasn't working, which the team notes is a common and understandable misreading given how attribution works when someone is already primed to distrust the medication.
His work as an electrician means climbing ladders and working near live panels most days, which he says makes the physical symptoms of an attack — the trembling hands specifically — feel less like an abstract anxiety symptom and more like an immediate occupational safety concern, a practical dimension worth naming since it shapes how urgently he wants the peripheral symptoms controlled regardless of what's happening underneath them.
Treating the trigger or the disorder
With a documented normal cardiac workup, propranolol as needed is a reasonable, low-risk way to blunt the physical sensations he's specifically catastrophizing about — reducing the tachycardia and tremor he says triggers his fear removes the exact cue that's escalating each attack.
Beta-blockade addresses the periphery, not the fear response itself, which originates centrally in the amygdala and related circuitry — the evidence for beta-blockers as monotherapy in panic disorder is genuinely weaker than for performance-specific anxiety, and there's a real risk this becomes symptom management that never touches the underlying disorder.
His own account — two SSRI trials each abandoned in under three weeks — sounds like inadequate exposure to a drug that needs four to six weeks to show its real effect, not a genuine treatment failure.
Both points are correct and not actually in conflict. As-needed propranolol can reduce the peripheral cues that fuel his catastrophic interpretation in the short term, which may make him more willing to commit to an adequate SSRI trial this time rather than abandoning it early again — used as a bridge toward the central-acting treatment, not a substitute for it.
Agreed: propranolol 10-20 mg as needed for acute symptom relief, alongside a restarted sertraline trial with an explicit six-week minimum commitment discussed and written into the plan before he leaves.